XML 35 R15.htm IDEA: XBRL DOCUMENT

Accrued Sales Tax	6 Months Ended
Dec. 31, 2019
Payables And Accruals [Abstract]
Accrued Sales Tax	Note 10. – Accrued Sales Tax During the fiscal year ended June 30, 2019, the Pharmacy segment business amended its sales tax position to exempt from sales tax consideration any revenue from sales of products and services to beneficiaries of government insurance programs to the extent reimbursed by the administrators of such programs. No sales taxes are included in the related reimbursement received from sales of such products and services from the government payers’ insurance programs. The Company is in the process of filing amended sales tax returns for periods still available to file such amended returns under the applicable statutes of limitations, and it intends to file amended sales tax returns for all such prior periods. Refunds have been received from two taxing authorities in the amounts claimed in such amended returns. Amounts claimed for these two taxing authorities believed to be estimable and probable of collection have been recorded in the quarter ended December 31, 2019 in the amount of $267. The subsidiary’s position with other local taxing authorities has not yet been determined probable of collection; therefore, the subsidiary has continued to accrue the amounts for sales tax estimates that it believes would be payable if its amended returns position is challenged and the Company does not prevail. The sales tax accrued at December 31, 2019 is $1,132 compared to $843 at June 30, 2019.

Accrued Sales Tax

6 Months Ended

Dec. 31, 2019

Note 10. – Accrued Sales Tax

During the fiscal year ended June 30, 2019, the Pharmacy segment business amended its sales tax position to exempt from sales tax consideration any revenue from sales of products and services to beneficiaries of government insurance programs to the extent reimbursed by the administrators of such programs. No sales taxes are included in the related reimbursement received from sales of such products and services from the government payers’ insurance programs. The Company is in the process of filing amended sales tax returns for periods still available to file such amended returns under the applicable statutes of limitations, and it intends to file amended sales tax returns for all such prior periods. Refunds have been received from two taxing authorities in the amounts claimed in such amended returns. Amounts claimed for these two taxing authorities believed to be estimable and probable of collection have been recorded in the quarter ended December 31, 2019 in the amount of $267. The subsidiary’s position with other local taxing authorities has not yet been determined probable of collection; therefore, the subsidiary has continued to accrue the amounts for sales tax estimates that it believes would be payable if its amended returns position is challenged and the Company does not prevail. The sales tax accrued at December 31, 2019 is $1,132 compared to $843 at June 30, 2019.